
Dr Howard Thom
PhD (University of Cambridge), MSc (University of Oxford), BA(Dub.)
Expertise
I am an Associate Professor in health economics. My interests are R for health economic modelling, value of information analysis, adaptive trial designs, network meta-analysis for limited networks, and structural uncertainty.
Current positions
Associate Professor in Health Economic Modelling and Evidence Synthesis
Bristol Medical School (PHS)Associate Professor
Bristol Medical School (PHS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Projects and supervisions
Research projects
NICE Guidelines Technical Support Unit (2023-2026)
Principal Investigator
Role
Co-Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/04/2023 to 31/03/2026
MICA: Reliable and Efficient Estimation of the Economic Value of medical Research (REEEVR)
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/12/2022 to 31/05/2024
Bristol TAG
Role
Co-Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/04/2022 to 31/03/2027
What is the value of adaptive designs? Estimating expected value of sample information for adaptive trial designs.
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/12/2019 to 30/11/2022
Efficient Sampling for Value Information Methods
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/01/2017 to 31/12/2017
Thesis supervisions
Publications
Recent publications
01/02/2025Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes
BMC Medical Research Methodology
Unanchored simulated treatment comparison on survival outcomes using parametric and Royston-Parmar models with application to lenvatinib plus pembrolizumab in renal cell carcinoma
BMC Medical Research Methodology
P25 REEEVR
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease
Journal of Comparative Effectiveness Research
Identifying the Optimum Strategy for Identifying Adults and Children With Celiac Disease
Value in Health